Efficacy and tolerability of vildagliptin in type 2 diabetic patients on hemodialysis

Efficacy and tolerability of vildagliptin in type 2 diabetic patients on hemodialysis

Anti‐diabetic agent‐related hypoglycemia is a serious complication in type 2 diabetic patients on hemodialysis. Therefore, we assessed the efficacy and tolerability of 24 weeks of monotherapy with vildagliptin, a dipeptidyl peptidase four inhibitor, which is a new class of antidiabetic agent. This o...

Full description

Bibliographic Details
Main Authors: Kume, Shinji, Uzu, Takashi, Takagi, Chieko, Kondo, Morihiro, Okabe, Tomoko, Araki, Shin‐ichi, Isshiki, Keiji, Takeda, Naoko, Kondo, Keiko, Haneda, Masakazu, Koya, Daisuke, Nishio, Yoshihiko, Kashiwagi, Atsunori, Maegawa, Hiroshi
Format: Online
Language:English
Published: Blackwell Publishing Ltd 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014953/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014953/

Similar Items